Advancing Life Sciences Automation: Insights from Emerson Exchange 2025
By Jim Cahill and Michalle Adkins, Emerson
At Emerson Exchange 2025, the Life Sciences team came together to share insights on advancing digital transformation in pharmaceutical manufacturing. The session emphasized collaboration across customers, partners, and experts, all working toward the shared goal of delivering therapies to patients. A technology roadmap was introduced, outlining a vision for more connected sites and systems across the enterprise. Key product development themes included foundational connectivity, modular enhancements, and a scalable data fabric designed to support integrated applications and intelligent platforms tailored to Life Sciences. The discussion underscored the importance of aligning technology with patient outcomes and how strategic innovation can help streamline operations and improve data visibility.
For teams navigating digital modernization in regulated environments, access the full article to gain practical direction and a clear sense of purpose.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.